Jean-Michel Rebibou

2.1k total citations
66 papers, 1.6k citations indexed

About

Jean-Michel Rebibou is a scholar working on Transplantation, Immunology and Nephrology. According to data from OpenAlex, Jean-Michel Rebibou has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Transplantation, 21 papers in Immunology and 14 papers in Nephrology. Recurrent topics in Jean-Michel Rebibou's work include Renal Transplantation Outcomes and Treatments (21 papers), Renal Diseases and Glomerulopathies (9 papers) and Cytomegalovirus and herpesvirus research (9 papers). Jean-Michel Rebibou is often cited by papers focused on Renal Transplantation Outcomes and Treatments (21 papers), Renal Diseases and Glomerulopathies (9 papers) and Cytomegalovirus and herpesvirus research (9 papers). Jean-Michel Rebibou collaborates with scholars based in France, United States and Belgium. Jean-Michel Rebibou's co-authors include Catherine Bresson–Vautrin, Jean‐Marc Chalopin, Pierre Tiberghien, Philippe Saas, Y Saint‐Hillier, Pierre‐Louis Carron, G Motté, Véronique Fournier, J. Chabod and Christophe Ferrand and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

Jean-Michel Rebibou

66 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean-Michel Rebibou France 24 678 474 340 275 245 66 1.6k
Adela Mattiazzi United States 21 1.0k 1.5× 516 1.1× 179 0.5× 279 1.0× 531 2.2× 56 1.8k
Nilüfer Broeders Belgium 20 659 1.0× 526 1.1× 148 0.4× 357 1.3× 204 0.8× 48 1.5k
Nina Tolkoff‐Rubin United States 18 613 0.9× 432 0.9× 287 0.8× 220 0.8× 208 0.8× 29 1.2k
John A. Daller United States 16 820 1.2× 702 1.5× 190 0.6× 359 1.3× 116 0.5× 45 1.5k
Renaud Snanoudj France 28 1.1k 1.6× 637 1.3× 389 1.1× 413 1.5× 539 2.2× 84 2.4k
Milagros Samaniego United States 27 1.3k 1.8× 866 1.8× 309 0.9× 262 1.0× 459 1.9× 76 2.0k
H W Sollinger United States 18 645 1.0× 646 1.4× 237 0.7× 259 0.9× 239 1.0× 70 1.5k
Valérie Châtelet France 16 678 1.0× 317 0.7× 635 1.9× 312 1.1× 601 2.5× 58 1.7k
P. R. Rajagopalan United States 17 844 1.2× 693 1.5× 172 0.5× 299 1.1× 131 0.5× 59 1.6k
Edmund Huang United States 28 1.2k 1.8× 798 1.7× 217 0.6× 177 0.6× 347 1.4× 85 2.0k

Countries citing papers authored by Jean-Michel Rebibou

Since Specialization
Citations

This map shows the geographic impact of Jean-Michel Rebibou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Michel Rebibou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Michel Rebibou more than expected).

Fields of papers citing papers by Jean-Michel Rebibou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Michel Rebibou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Michel Rebibou. The network helps show where Jean-Michel Rebibou may publish in the future.

Co-authorship network of co-authors of Jean-Michel Rebibou

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Michel Rebibou. A scholar is included among the top collaborators of Jean-Michel Rebibou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Michel Rebibou. Jean-Michel Rebibou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joseph, Adrien, Stéphanie Harel, Laurent Mesnard, et al.. (2024). Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes. Nephrology Dialysis Transplantation. 39(12). 2067–2078. 4 indexed citations
2.
Paindavoine, Michel, Patrick Bard, Jean-Michel Rebibou, et al.. (2023). Automated evaluation with deep learning of total interstitial inflammation and peritubular capillaritis on kidney biopsies. Nephrology Dialysis Transplantation. 38(12). 2786–2798. 7 indexed citations
3.
Pellequer, Yann, Jean-Michel Rebibou, Isabelle Séverin, et al.. (2021). Development of a new methodology to determine size differences of nanoparticles with nanoparticle tracking analysis. Applied Nanoscience. 11(7). 2129–2141. 1 indexed citations
4.
Silva, Stein, Bernard Georges, C. Cartery, et al.. (2020). Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients. Annals of Intensive Care. 10(1). 27–27. 71 indexed citations
5.
Quenot, Jean‐Pierre, Julie Helms, Abderrahmane Bourredjem, et al.. (2019). Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial. Annals of Intensive Care. 9(1). 75–75. 20 indexed citations
6.
Louis, Magali, Jonathan Cottenet, Arnaud Salmon‐Rousseau, et al.. (2019). Prevalence and incidence of kidney diseases leading to hospital admission in people living with HIV in France: an observational nationwide study. BMJ Open. 9(5). e029211–e029211. 6 indexed citations
7.
Crépin, Thomas, Charline Vauchy, Caroline Laheurte, et al.. (2019). Maladie rénale chronique et immunosénescence prématurée : données et perspectives. Néphrologie & Thérapeutique. 16(1). 9–18. 7 indexed citations
8.
Bamoulid, Jamal, et al.. (2018). Antithymocytes globulins: Time to revisit its use in kidney transplantation?. International Reviews of Immunology. 37(4). 183–191. 7 indexed citations
9.
Bamoulid, Jamal, et al.. (2017). Antithymocyte globulins in renal transplantation—from lymphocyte depletion to lymphocyte activation: The doubled-edged sword. Transplantation Reviews. 31(3). 180–187. 7 indexed citations
10.
Courivaud, Cécile, Jamal Bamoulid, Caroline Roubiou, et al.. (2014). Alloimmune Responses and Atherosclerotic Disease After Kidney Transplantation. Transplantation. 99(1). 220–225. 10 indexed citations
11.
Macé, G., Sylvain Audia, Jean-Michel Rebibou, et al.. (2013). Severe Seoul hantavirus infection in a pregnant woman, France, October 2012. Eurosurveillance. 18(17). 20464–20464. 42 indexed citations
12.
Bamoulid, Jamal, Cécile Courivaud, Béatrice Gaugler, et al.. (2011). Thymic function, anti-thymocytes globulins, and cancer after renal transplantation. Transplant Immunology. 25(1). 56–60. 14 indexed citations
13.
Courivaud, Cécile, Jamal Bamoulid, Marina Deschamps, et al.. (2010). Prolonged CD4 T Cell Lymphopenia Increases Morbidity and Mortality after Renal Transplantation. Journal of the American Society of Nephrology. 21(5). 868–875. 77 indexed citations
14.
Heyd, Bruno, E Justrabo, Jean-Michel Rebibou, et al.. (2005). Successful Hepatorenal Transplantation in Hereditary Amyloidosis Caused by a Frame-Shift Mutation in Fibrinogen Aa -Chain Gene. American Journal of Transplantation. 6(3). 632–635. 22 indexed citations
15.
Kazory, Amir, Bruno Challier, Catherine Bresson–Vautrin, et al.. (2004). LONG-TERM TOXICITY OF ANTITHYMOCYTE GLOBULIN INDUCTION MAY VARY WITH CHOICE OF AGENT: A SINGLE-CENTER RETROSPECTIVE STUDY. Transplantation. 77(7). 1029–1033. 59 indexed citations
16.
Rebibou, Jean-Michel, et al.. (1998). RECURRENCE OF HEMOLYTIC-UREMIC SYNDROME IN RENAL TRANSPLANT RECIPIENTS. Transplantation. 65(10). 1405–1407. 48 indexed citations
17.
Fournier, Véronique, et al.. (1998). Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.. PubMed. 49(4). 232–5. 46 indexed citations
18.
Gibey, R, et al.. (1998). Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients. Nephrology Dialysis Transplantation. 13(11). 2890–2893. 53 indexed citations
19.
Carron, Pierre‐Louis, Jean-Michel Rebibou, F. Aubin, et al.. (1998). CD4 LYMPHOCYTOPENIA AS A RISK FACTOR FOR SKIN CANCERS IN RENAL TRANSPLANT RECIPIENTS. Transplantation. 65(9). 1270–1272. 95 indexed citations
20.
He, Cijiang, Jean-Michel Rebibou, Marie‐Noelle Péraldi, Q. Meulders, & Eric Rondeau. (1991). Growth factor-like effect of urokinase type plasminogen activator in human renal cells. Biochemical and Biophysical Research Communications. 176(3). 1408–1416. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adela Mattiazzi Breakdown of academic impact, for papers by Nilüfer Broeders Breakdown of academic impact, for papers by Nina Tolkoff‐Rubin Breakdown of academic impact, for papers by John A. Daller Breakdown of academic impact, for papers by Renaud Snanoudj Breakdown of academic impact, for papers by Milagros Samaniego Breakdown of academic impact, for papers by H W Sollinger Breakdown of academic impact, for papers by Valérie Châtelet Breakdown of academic impact, for papers by P. R. Rajagopalan Breakdown of academic impact, for papers by Edmund Huang
Rankless by CCL
2026